Rocket Pharmaceuticals is trading 8.3% higher at $3.40 today, despite a lack of fresh company-specific news, earnings, or regulatory headlines to explain the move.
- The stock closed at $3.14 on July 29, 2026, and the current jump appears to reflect idiosyncratic pre-market interest.
- Broader market futures are only moderately higher, suggesting the price action is independent of general market sentiment.
- No clinical data or corporate updates have been released that would typically trigger such a significant percentage gain.